Clinical effects and safety of intra-arterial infusion chemotherapy with lipiodol versus intra-arterial infusion chemotherapy alone for treatment of advanced hepatocellular carcinoma

2024-9-13

Dose-reduction of bevacizumab in atezolizumab plus bevacizumab therapy extends treatment duration with disease control in patients with hepatocellular carcinoma

2024-9-12

The usefulness of serum interleukin-6 as a predictor of response to atezolizumab plus bevacizumab combination treatment in hepatocellular carcinoma

2024-9-12

Clinical impact of skeletal muscle mass and nutritional status in patients with recurrent or advanced gastric cancer treated with nivolumab

2024-9-12

Social characteristics of culturally and linguistically diverse cancer patients enrolled in early phase clinical trials in South-Western Sydney

2024-9-12

Identification of biomarkers for assessing treatment efficacy of chemotherapy plus nivolumab as the first line in patients with unresectable advanced or recurrent gastric cancer: a multicenter study

2024-9-12

A Scoping Review of Population Diversity in the Common Genomic Aberrations of Clear Cell Renal Cell Carcinoma

2024-9-9

Clinicopathological factors predicting pathological complete response to neoadjuvant anti-HER2 therapy in HER2-positive breast cancer

2024-9-9

A Novel Index Including Age, Sex, hTERT, and Methylated RUNX3 Is Useful for Diagnosing Early Gastric Cancer

2024-9-5

Development of a diagnostic model for pancreatic ductal adenocarcinoma using machine learning and blood-based miRNAs

2024-9-4

Utility of assessing early tumor shrinkage as an efficacy predictor in patients with non–surgically indicated or recurrent esophageal cancer treated with nivolumab plus ipilimumab

2024-8-29

ASSOCIATION OF INSULIN RECEPTOR SUBSTRATE 1 (IRS 1) EXPRESSION IN THE PROGNOSIS OF HEAD AND NECK SQUAMOUS CELL CARCINOMA - A SYSTEMATIC REVIEW AND META ANALYSIS

2024-8-26

Pulmonary adenocarcinoma with enteric differentiation (PAED) without TTF-1 expression is a very rare subtype with limited treatment options and poor prognosis

2024-8-19

Identification and initial validation of neuroendocrine differentiation as a novel prognostic factor in stage II colorectal cancer patients

2024-8-19

Long-term Survival Outcomes and Risk Factors for Axillary and Locoregional Recurrence in Japanese Patients with Sentinel Node–positive Breast Cancer Treated in Accordance with the ACOSOG Z0011 Strategy

2024-8-19

Claudin-1 in head and neck squamous cell carcinoma

2024-8-14

Assessment of Cardiovascular Events Caused by New Generation Androgen Receptor Pathway Inhibitors Used for Prostate Cancer: A Real-World Study in Japan

2024-8-14

Significance of gene polymorphism and gene expression of BACE2 in Swedish patients with colorectal cancer

2024-8-14

How to prevent local recurrence of sacral chordoma treated with carbon-ion radiotherapy: An analysis of the risk factors of local failure and an adequate disease margin

2024-8-12

High expression of cancer-derived sialylated immunoglobulin G: a novel biomarker for poor prognosis in laryngeal squamous cell carcinoma

2024-8-12

The overexpressed microRNAs miRs-182, 155, 493, 454 and U6 snRNA, and underexpressed let-7c, miR-328 and miR-451a as potential biomarkers in invasive breast cancer and their clinicopathological significance

2024-8-12

Real-World Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System Database for Asciminib

2024-8-5

The Glasgow Prognostic Score as a Predictor of Survival After Chemoradiotherapy for Limited-Disease Small Cell Lung Cancer

2024-8-5

Chronic Lymphocytic Leukemia in Pregnancy: A Review of the Available Literature and the Pharmacological Challenges in Management

2024-7-31

The Comparison of FLOT and DCF Regimens as Perioperative Treatment for Gastric Cancer

2024-7-30

Interleukin-7 risk allele, lymphocyte counts, and autoantibodies for prediction of risk of immune-related adverse events in patients receiving Atezolizumab plus Bevacizumab therapy for unresectable hepatocellular carcinoma

2024-7-30

Effect of Hydration with Bicarbonate Ringer’s Solution on Cisplatin-Induced Acute Kidney Injury in Patients with Esophageal Cancer: A Retrospective Cohort Study

2024-7-29

Prognostic Impact of Reactive Oxygen Species Modulator 1 in Surgically Resected Epidermal Growth Factor Receptor-Mutant Lung Adenocarcinomas

2024-7-25

Integrating AI-driven Wearable Technology in Oncology Decision Making: A Narrative Review

2024-7-25

Ubiquitin-Specific Protease 52 as a Prognostic Biomarker Correlates with Tumor Microenvironment and Therapy Response in Colorectal Cancer

2024-7-24

Changes in mutations of cell-free DNA and liver tumor tissue in patients with advanced hepatocellular carcinoma before and after introduction of lenvatinib

2024-7-24

SIRT1 promotes chemoradiotherapy resistance in esophageal squamous cell carcinoma.

2024-7-22

Factors affecting recurrence and survival in Stage IIA colon cancer patients

2024-7-22

Artificial Intelligence-driven Prediction Revealed CFTR Associated With Therapy Outcome Of Breast Cancer: A Feasibility Study

2024-7-18

Development of a Patient-Centered Pathway of Care for Retinoblastoma Patients: A Mixed-Methods Pilot Study

2024-7-17

Serum Uric Acid Level May Be a Predictive Factor for BRAF V600E Mutation in Older Patients with Metastatic Colorectal Cancer: An Exploratory Analysis

2024-7-17

Zinc Supplementation in Head and Neck Cancer: Prevention of Chemo-Radio-Induced Complications and an Opportunity for Treatment

2024-7-17

Experience and prognostic analysis with avelumab switch maintenance treatment in metastatic urothelial carcinoma

2024-7-17

Chronic Myeloid Leukemia in Adolescents and Young Adults: Clinicopathological Variables and Outcomes.

2024-7-16

Relationship between Anaplastic Lymphoma Kinase (ALK) Inhibitors and Epileptic Seizure Disorder: A Post-Marketing Surveillance Study.

2024-5-20

Paraneoplastic Hyperthyroidism in advanced testicular non-seminomatous germ cell tumors: Prevalence and clinical Management

2024-5-6

Myocardial Infarction in Chronic Myeloid Leukemia: Results from Nationwide Readmission Database

2024-5-3

Comprehensive Genomic Characterization in Ovarian Low-Grade and chemosensitive and chemoresistant High-Grade Serous Carcinomas

2024-5-3

Plasma Cell-Free Adenomatous Polyposis Coli Gene Promoter Methylation as a Prognostic Biomarker for Hepatocellular Carcinoma

2024-3-25

Potential of Using qFibrosis Analysis to Predict Recurrent and Survival Outcome of Patients with Hepatocellular Carcinoma after Hepatic Resection

2024-3-25

Treatment Outcomes of Patients with Ependymoma Receiving Radiotherapy: A Single Institution Experience

2024-3-12

Decision-Making at Swissmedic, the Swiss Regulatory Agency, with a Focus on (Neo)adjuvant Cancer Treatments

2024-3-5

Nesprin1 Deficiency Is Associated with Poor Prognosis of Renal Cell Carcinoma and Resistance to Sunitinib Treatment

2024-3-5

Comprehensive Study of Chromosomal Copy Number Variations and Genomic Variations Predicting Overall Survival in Myelodysplastic Syndromes

2024-3-5

Arterial-Portal Venous Shunt after Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma Patients: Risk factors and Impact on Patient Survival

2024-2-26